Topics in antiviral medicine
About the journal
Topics in antiviral medicine is a journal in United States. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- ISSN
- 2161-5861 · 2161-5853
- Country
- United States
- Access
- Not open access / not declared
- Official website
- http://www.iasusa.org/pub/current.html
Index listings
- MEDLINE · 2011-01-01
- PUBMED · 2023-03-31
- Indexing
- MEDLINE · PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
92
Last recorded publication year
2021
h-index
8
i10-index
4
From OpenAlex open data (CC0).
Editorial & policy2
- Open references deposited at Crossref
- 86%
- ORCID iDs in current deposits
- 0%
Identity & continuity3
- Alternate titles
- Top Antivir MedIAS-USA topics in antiviral medicine
- Source type
- journal
- NLM unique ID (PubMed)
- 101560274
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- COVID-19 Clinical Research Studies
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
- COVID-19 Impact on Reproduction
- COVID-19 Impact on Reproduction
Show all subjects (50)
- Long-Term Effects of COVID-19
- HIV/AIDS Research and Interventions
- Long-Term Effects of COVID-19
- HIV Research and Treatment
- vaccines and immunoinformatics approaches
- vaccines and immunoinformatics approaches
- Respiratory viral infections research
- Respiratory viral infections research
- HIV, Drug Use, Sexual Risk
- SARS-CoV-2 detection and testing
- COVID-19 and healthcare impacts
- HIV, Drug Use, Sexual Risk
- SARS-CoV-2 detection and testing
- COVID-19 and healthcare impacts
- COVID-19 epidemiological studies
- COVID-19 epidemiological studies
- HIV/AIDS drug development and treatment
- HIV Research and Treatment
- Immune cells in cancer
- Pneumocystis jirovecii pneumonia detection and treatment
- HIV-related health complications and treatments
- COVID-19 and Mental Health
- interferon and immune responses
- Immunotherapy and Immune Responses
- interferon and immune responses
- Immune cells in cancer
- Immunotherapy and Immune Responses
- COVID-19 and Mental Health
- Vaccine Coverage and Hesitancy
- Vaccine Coverage and Hesitancy
- Monoclonal and Polyclonal Antibodies Research
- Viral Infections and Outbreaks Research
- Monoclonal and Polyclonal Antibodies Research
- Global Maternal and Child Health
- Hepatitis C virus research
- Pneumocystis jirovecii pneumonia detection and treatment
- Viral Infections and Outbreaks Research
- Immunodeficiency and Autoimmune Disorders
- Computational Drug Discovery Methods
- Computational Drug Discovery Methods
- Influenza Virus Research Studies
- Global Maternal and Child Health
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ